Evidence map›Paper›PMID 35474308›Full record

ArticleNature communications2022

A periplasmic cinched protein is required for siderophore secretion and virulence of Mycobacterium tuberculosis.

Lei Zhang, James E Kent, Meredith Whitaker, David C Young, Dominik Herrmann, Alexander E Aleshin, Ying-Hui Ko, Gino Cingolani, Jamil S Saad, D Branch Moody and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Structure, assembly, and mechanism of the MmpL family of transporters.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Structural elucidation of the hexameric MmpS4-MmpL4 complex frombioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Structural and functional analysis of theProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. TargetingRSC medicinal chemistry · 2023
    Review
  15. Intricate link between siderophore secretion and drug efflux inAntimicrobial agents and chemotherapy · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Radiometal chelators for infection diagnostics.Frontiers in nuclear medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Lei ZhangDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID 0000-0002-8566-6068
James E KentCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.ORCID 0000-0002-4856-525X
Meredith WhitakerDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, 10021, USA.
David C YoungDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Dominik HerrmannDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID 0000-0002-7187-3357
Alexander E AleshinCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Ying-Hui KoDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Gino CingolaniDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.ORCID 0000-0002-9206-9640
Jamil S SaadDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.ORCID 0000-0001-9503-6484
D Branch MoodyDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.ORCID 0000-0003-2306-3058
Francesca M MarassiCancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
Sabine EhrtDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, 10021, USA.ORCID 0000-0002-7951-2310
Michael NiederweisDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. mnieder@uab.edu.ORCID 0000-0003-4068-8092
University of Alabama at Birmingham · USSanford Burnham Prebys Medical Discovery Institute · USBrigham and Women's Hospital · USCornell University · USThomas Jefferson University · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
Membrane Protein Effectors of Pathogen Interactions With HostR35GM118186 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Francesca M Marassi · 2016 to 2026
$8.5M
Chemical Biological Discovery of Lipid Virulence Factors in the Major Bacterial PathogensR01AI165573 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2022 to 2025
$3.0M
Mechanism of Viral Genome Delivery into CellsR35GM140733 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CINGOLANI, GINO · 2021 to 2025
$2.8M
Siderophore secretion by Mycobacterium tuberculosisR21AI151239 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NIEDERWEIS, MICHAEL · 2021 to 2022
$431k
A High-Throughput Crystallization Platform at JeffersonS10OD023479 · OD · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2019 to 2019
$94k
NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA056036NIAID NIH HHS R01 AI049313NIAID NIH HHS R01 AI165573NIAID NIH HHS R21 AI151239NIGMS NIH HHS R35 GM118186NIGMS NIH HHS R35 GM140733NIH HHS S10 OD023479
6 · The paper itself

Abstract

Iron is essential for growth of Mycobacterium tuberculosis, the causative agent of tuberculosis. To acquire iron from the host, M. tuberculosis uses the siderophores called mycobactins and carboxymycobactins. Here, we show that the rv0455c gene is essential for M. tuberculosis to grow in low-iron medium and that secretion of both mycobactins and carboxymycobactins is drastically reduced in the rv0455c deletion mutant. Both water-soluble and membrane-anchored Rv0455c are functional in siderophore secretion, supporting an intracellular role. Lack of Rv0455c results in siderophore toxicity, a phenotype observed for other siderophore secretion mutants, and severely impairs replication of M. tuberculosis in mice, demonstrating the importance of Rv0455c and siderophore secretion during disease. The crystal structure of a Rv0455c homolog reveals a novel protein fold consisting of a helical bundle with a 'cinch' formed by an essential intramolecular disulfide bond. These findings advance our understanding of the distinct M. tuberculosis siderophore secretion system.

Indexed as

Mycobacterium tuberculosisTuberculosisAnimalsIronMiceSiderophoresVirulenceIronSiderophores

Identifiers

PMID35474308
PMCPMC9042941
OpenAlexW4224980409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.